Skip to main content
Premium Trial:

Request an Annual Quote

Nabsys Raises $7M in Series B Funding to Boost Development of Nanopore Sequencing Platform

Premium

This story was originally published on February 17, 2010.

Nabsys has raised $7 million from a Series B equity financing round, the company said today.

The Providence, RI-based company will use the funding to accelerate the development and commercialization of its nanopore-based DNA sequencing platform.

The startup company, which resulted from the merger of two Brown University spinouts in late 2006 (see In Sequence 1/9/2007), is working on a sequencing platform that combines sequencing-by-hybridization with solid-state electrically-addressable nanopore arrays.

Stata Venture Partners led the Series B round, in which existing investor Point Judith Capital participated as well. The funding follows almost a year after Nabsys closed a $4 million Series A equity round (see In Sequence 5/5/2009).

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.